Direct Intracranial Extension of Malignant Eccrine Spiradenoma of the Face

Abstract

Malignant eccrine spiradenomas are exceedingly rare tumours. They are aggressive tumours normally arising in long-standing benign eccrine spiradenomas. We present a case of malignant eccrine spiradenoma of the right side of the face with direct intracranial extension without distant metastasis. A 48 years old woman presented with a large exophytic tumour on the right side of her face. Radiological imaging of the head and neck region revealed extensive invasion of the facial tissues around right orbit, maxilla and extension into the middle cranial fossa involving the right temporal lobe. She underwent craniotomy and debulking of the right temporal lobe and biopsy of the facial tumour. Histopathological findings were consistent with malignant eccrine spiradenoma. This is a rare case of facial malignant eccrine spiradenoma with direct intracranial extension with no distant metastasis. A literature search revealed that it is first case to be reported of this kind.KeywordsEccrine carcinoma; Spiradenoma; Adnexal carcinoma; Malignant eccrine spiradenoma

Direct intracranial invasion of eccrine spiradenocarcinoma of the scalp: a case report and literature review

“…The present report describes the first case of scalp SC with intracranial extension, as the five cases described above showed no intracranial extension. To the best of our knowledge, only one case report has described eccrine SC with direct intracranial extension [ 10 ]. That case involved a large exophytic tumor on the face invading the middle cranial fossa.…”

Multiple fungating exophytic nodules secondary to metastatic spiradenocarcinoma with direct spinal cord invasion

“…Even though ES usually arises from a benign eccrine spiradenoma, de novo appearance of ES has also been described . ES has rarely been associated with direct intracranial extension due to extensive facial involvement without distant metastasis …”

Challenges in diagnosis and management of a spiradenocarcinoma: a comprehensive literature review

“…Computed tomography was the preferred modality, used in 49.1% of these cases, followed by magnetic resonance imaging (MRI) (32.7%), X-ray (30.9%), bone scan (23.6%), ultrasound (20%), positron emission tomography (PET)/computed tomography (CT) (14.5%) and finally mammography (10.9%). [4][5][6][8][9][10][11][54][55][56][57][58][60][61][62][63][67][68][69][73][74][75][77][78][79] Staiger et al have recently recommended that patients presenting with confirmed malignant spiradenoma be evaluated with an MRI and fluorodeoxyglucose (FDG)-PET/CT. 74 Details regarding a fineneedle aspirate or punch biopsy was provided for 76 case reports and case series, representing 86 (61.9%) cases.…”

“…This pre-operative test was performed 40.7% of the time, with the majority of surgeons electing to proceed firstly with excisional biopsy or wide local excision. [4][5][6][7][8][9][10][11][12][18][19][20][21][22][24][25][26][27][28][29][54][55][56][57][58][60][61][62][63][64][65][66][67][68][69][70][71][72][73][74][75][77][78][79][80][81][82][83][84][85][86][8...…”